Reconstructed MRI Images Guide Radiotherapy Treatment
|
By MedImaging International staff writers Posted on 07 Jul 2021 |
|
Image: The MRgRT treatment room at the ICR (Photo courtesy of ICR)
An artificial intelligence (AI) algorithm that reconstructs magnetic resonance imaging (MRI) images of moving tumors in seconds could optimize radiotherapy (RT) treatment, according to a new study.
Developed at The Institute of Cancer Research (ICR; London, United Kingdom), The Royal Marsden NHS Foundation Trust (London, United Kingdom), the German Cancer Research Center (DKFZ; Heidelberg, Germany), and other institutions, magnetic resonance guided radiotherapy (MRgRT) is based on a deep radial convolutional neural network (Dracula) algorithm that replicates four-dimensional (4D) MRI images, including tumors and healthy organs, from low quality images containing artifacts.
By using data on the spatial dimensions and respiratory phases of a patient's tumor and surrounding organs, Dracula can produce 4D MRI and mid-position images from scans previously considered unacceptable for MRgRT. Clinically, the MRI images reconstructed by Dracula can be used to guide a linear accelerator (Linac), thus serving as a novel platform to locate and deliver precisely targeted RT doses to tumors, minimizing the risk of affecting healthy organs. The study was published in the June 2021 issue of Radiotherapy and Oncology.
“Using an AI to rapidly reconstruct 4D MRI images of a cancer patient's anatomy lets us accurately determine the location of tumors and characterize their motion right before RT treatment,” said senior author Andreas Wetscherek, PhD, of the ICR. “It would be especially useful for cancers where we need to avoid the healthy organs around the tumor, such as pancreatic cancer, which currently limits the delivery of high doses of radiation to the tumor.”
To treat patients with tumors that move as they breathe, 4D MRI images are needed to show the 3D volume of the tumor and surrounding organs at different time points during breathing, known as a respiratory phase. By combining respiratory phases, the midposition (the average position of the tumor) is calculated, helping to accurately plan MRgRT. An alternative is to have a patient hold their breath, but this can be strenuous for the patient and makes treatment longer and more difficult.
Related Links:
The Institute of Cancer Research
The Royal Marsden NHS Foundation Trust
German Cancer Research Center
Developed at The Institute of Cancer Research (ICR; London, United Kingdom), The Royal Marsden NHS Foundation Trust (London, United Kingdom), the German Cancer Research Center (DKFZ; Heidelberg, Germany), and other institutions, magnetic resonance guided radiotherapy (MRgRT) is based on a deep radial convolutional neural network (Dracula) algorithm that replicates four-dimensional (4D) MRI images, including tumors and healthy organs, from low quality images containing artifacts.
By using data on the spatial dimensions and respiratory phases of a patient's tumor and surrounding organs, Dracula can produce 4D MRI and mid-position images from scans previously considered unacceptable for MRgRT. Clinically, the MRI images reconstructed by Dracula can be used to guide a linear accelerator (Linac), thus serving as a novel platform to locate and deliver precisely targeted RT doses to tumors, minimizing the risk of affecting healthy organs. The study was published in the June 2021 issue of Radiotherapy and Oncology.
“Using an AI to rapidly reconstruct 4D MRI images of a cancer patient's anatomy lets us accurately determine the location of tumors and characterize their motion right before RT treatment,” said senior author Andreas Wetscherek, PhD, of the ICR. “It would be especially useful for cancers where we need to avoid the healthy organs around the tumor, such as pancreatic cancer, which currently limits the delivery of high doses of radiation to the tumor.”
To treat patients with tumors that move as they breathe, 4D MRI images are needed to show the 3D volume of the tumor and surrounding organs at different time points during breathing, known as a respiratory phase. By combining respiratory phases, the midposition (the average position of the tumor) is calculated, helping to accurately plan MRgRT. An alternative is to have a patient hold their breath, but this can be strenuous for the patient and makes treatment longer and more difficult.
Related Links:
The Institute of Cancer Research
The Royal Marsden NHS Foundation Trust
German Cancer Research Center
Digital X-Ray Detector Panel
Acuity G4
Mobile X-Ray System
K4W
Computed Tomography System
Aquilion ONE / INSIGHT Edition
Biopsy Software
Affirm® Contrast
Latest Nuclear Medicine News
- MR-Guided Cardiac Mapping System Enables Radiation-Free Procedures
- New Imaging Tool Sheds Light on Tumor Fat Metabolism
- PET Tracer Enables Noninvasive Measurement of Beta Cell Mass
- Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
- Cancer “Flashlight” Shows Who Can Benefit from Targeted Treatments
- PET Imaging of Inflammation Predicts Recovery and Guides Therapy After Heart Attack
- Radiotheranostic Approach Detects, Kills and Reprograms Aggressive Cancers
- New Imaging Solution Improves Survival for Patients with Recurring Prostate Cancer
- PET Tracer Enables Same-Day Imaging of Triple-Negative Breast and Urothelial Cancers
- New Camera Sees Inside Human Body for Enhanced Scanning and Diagnosis
- Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections
- New Imaging Approach Could Reduce Need for Biopsies to Monitor Prostate Cancer
- Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
- Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
- Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
- Innovative PET Imaging Technique to Help Diagnose Neurodegeneration
Channels
Radiography
view channel
Simple Chest X-Ray Measure Predicts Survival After Lung Cancer Surgery
Obstructive ventilatory disorder, marked by airflow limitation that reduces breathing efficiency, increases postoperative risk in patients with lung cancer. Although surgery offers the best chance of cure,... Read more
AI Detection Tool Improves Identification of Lobular Breast Cancer
Breast cancer screening seeks early detection, yet some subtypes remain difficult to visualize on mammography, risking delayed diagnosis. On average, 1 in 20 women worldwide will develop breast cancer,... Read more
MRI
view channel
AI Body Composition MRI Analysis Predicts Cardiometabolic Disease Risk
Cardiometabolic disease, driven by interactions between cardiovascular and metabolic systems, is a leading cause of morbidity and mortality. Risk assessment often relies on body mass index, which overlooks... Read more
Blood-Brain Barrier Imaging Adds Risk Insight to Standard Stroke MRI
Acute ischemic stroke requires fast, precise decisions on reperfusion and bleeding risk, yet routine imaging gives limited insight into vascular integrity. Clinicians need ways to predict outcomes and... Read more
Ultrasound
view channel
AI Robotic Ultrasound System Automates Echocardiography and Improves Consistency
Echocardiography, an ultrasound examination of the heart, is central to diagnosing and managing cardiovascular disease. Many services struggle with limited availability of skilled sonographers, variable... Read more
Whole Cross-Section Ultrasound System Enables Operator-Independent Imaging
Conventional ultrasound is central to bedside imaging but is limited by a narrow field of view and operator variability. Comprehensive cross-sectional assessment typically requires computed tomography... Read more
General/Advanced Imaging
view channel
New Proton Therapy Platform Integrates into Existing Radiotherapy Departments
Mevion Medical Systems (Littleton, MA, USA) has introduced the MEVION S250-FIT Proton Therapy System to the European radiation oncology community at ESTRO 2026, the first proton therapy platform designed... Read more
3D-Printed Intraoral Device Enhances Head and Neck Radiotherapy Accuracy
Ensuring consistent immobilization and soft-tissue positioning is central to safe, effective head and neck radiotherapy, where protection of organs at risk must be balanced with dose accuracy.... Read more
Molecular Imaging Agent Shows Promise for Endometriosis Detection and Monitoring
Diagnosing endometriosis remains challenging, particularly for superficial peritoneal endometriosis, the most common subtype, which is often missed on conventional imaging and typically requires laparoscopic... Read more
Imaging IT
view channel
Interactive AI Tool Supports Explainable Lung Nodule Assessment
Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read more
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare Highlights AI-Supported Radiation Therapy Tools at ESTRO 2026
At the European Society for Radiotherapy and Oncology (ESTRO) 2026 Congress in Stockholm, GE HealthCare is highlighting Intelligent Radiation Therapy (iRT), MIM Software innovations, and BK Medical surgical... Read more
